D-Ribulose 5-phosphate



Compound IDCDAMM01363
Common nameD-Ribulose 5-phosphate
IUPAC name(2,3,5-trihydroxy-4-oxopentyl) dihydrogen phosphate
Molecular formulaC5H11O8P

Experimental data

Retention time5.05
Adduct[M+NH4]+
Actual mz248.051
Theoretical mz248.053
Error7.75
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.9826

Identifiers and class information

Inchi keyFNZLKVNUWIIPSJ-UHNVWZDZSA-N
SmilesO=C(CO)C(O)C(O)COP(=O)(O)O
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)2
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)2
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)11
Number of reactive functional groups (#rtvFG)2
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)230.111
Computed dipole moment(dipole)3.974
Total solvent accessible surface area (SASA)426.176
Hydrophobic component of SASA (FOSA)88.864
Hydrophilic component of SASA (FISA)332.533
Pie component of the SASA (PISA)0
Weakly polar component of the SASA (WPSA)4.779
Total solvent accesible volume (volume)679.988
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)11.1
Free energy of solvation of dipole (dip^2/V)0.0232204
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0520911
Globularity descriptor (glob)0.877492
Predicted polarizability in cubic angstroms (QPpolrz)13.996
Predicted hexadecane/gas partition coefficient (QPlogPC16)7.716
Predicted octanol/gas partition coefficient (QPlogPoct)16.672
Predicted water/gas partition coefficient (QPlogPw)17.373
Predicted octanol/water partition coefficient (QPlogPo/w)-1.815
Predicted aqueous solubility (QPlogS)-0.312
Conformation-independent predicted aqueous solubility (CIQPlogS)-0.355
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)0.101
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)0.446
Predicted brain/blood partition coefficient (QPlogBB)-2.967
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)0.203
Predicted skin permeability, log Kp (QPlogKp)-6.592
PM3 calculated ionization potential (IP(ev))10.265
PM3 calculated electron affinity (EA(eV))-0.167
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)-1.646
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)10.047
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)160.053
Number of nitrogen and oxygen atoms (#NandO)8
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9H228S1PR5Sphingosine 1-phosphate receptor Edg-8T50089SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SwissTargetPrediction and SEA
P43657LPAR6Lysophosphatidic acid receptor 6T13484SEA
Q9H1C0LPAR5Lysophosphatidic acid receptor 5T18616SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
Q9UBY5LPAR3Lysophosphatidic acid receptor Edg-7T95923SEA
Q92633LPAR1Lysophosphatidic acid receptor Edg-2T92640SEA
Q99677LPAR4Lysophosphatidic acid receptor 4T58130SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T50089DI0275Multiple sclerosis[ICD-11: 8A40]Q9H228S1PR5
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T95923DI0146Fibrosis[ICD-11: GA14-GC01]Q9UBY5LPAR3
T95923DI0399Systemic sclerosis[ICD-11: 4A42]Q9UBY5LPAR3
T92640DI0146Fibrosis[ICD-11: GA14-GC01]Q92633LPAR1
T92640DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q92633LPAR1
T92640DI0351Psoriasis[ICD-11: EA90]Q92633LPAR1
T92640DI0399Systemic sclerosis[ICD-11: 4A42]Q92633LPAR1

Copyright © 2025